Glenmark’s novel monoclonal antibody GBR 830 enters human trials
GBR 830 is an antagonistic monoclonal antibody with first in class potential for the treatment of autoimmune diseases targeting…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Archive
Glenmark and JJ gain entry in Guinness World Record on Doctor’s Day
Creates 66,311 bottles mosaic of an expectorant brand in the shape of a smile
‘Ashland already has more than $1 billion sales coming from the Asia Pac region’
Luis Fernandez-Moreno, Senior Vice President, Ashland speaks to Viveka Roychowdhury on the company's investment in the Asia Pac…
Clariant inaugurates new India headquarters at Navi Mumbai
The new facility will house around 400 employees across the various service functions
Lonza invests in single-use technology and facility upgrades for clinical ADC manufacturing
The addition of single-use manufacturing systems will reduce potential product contamination risks and allow for increased…
NuLEAP and Venostic in agreement
To offer computer systems validation and IT compliance services in India
DKSH buys Zeus Química
With the acquisition of Zeus Química, DKSH business unit performance materials is continuing its targeted strategic expansion
Cognex DataMan 8050 Series launched
Within the pharmaceutical industry, stringent legislation exists to combat counterfeit goods by ensuring that each product can be…
Waters introduces Xevo G2-XS QTof and Xevo TQ-S micro mass spectrometers
Waters Corporation has launched two new Xevo mass spectrometers and expanded the ionKey/MS System at the 62nd conference of the…
Piramal’s NCE research shares preclinical efficacy data for two promising molecules
Piramal Life Sciences - NCE Research, a division of Piramal Enterprises Ltd (PEL), made poster presentations for drugs in early…
Tau Imaging Agents to Advance Treatment of Alzheimer
Tau imaging agents could offer the next frontier in neuroimaging for diseases such as Alzheimer’s disease (AD) and other forms of…
Hope Against Hope
The Modi-led Government will present its first General Budget on July 10. Representatives of pharmaceutical companies and industry…
‘There is a greater need to set-up healthcare facilities in the metros, Tier-I and Tier-II cities in…
In its pre-budget memorandum, the Organisation of Pharmaceutical Producers of India (OPPI) proposed budgetary measures in key…
‘GOI can consider providing customs duty exemptions to all life saving drugs’
Bourgeoning population, growing incidence of chronic and lifestyle diseases and increasing healthcare costs are calling for…
‘All excisable goods used for R&D purposes should be exempted from Central Excise Duty’
It is high time that the Government takes a serious note of the issues and concerns of the Indian pharmaceutical industry. The…
‘Invest $4-5 bn each year in the next five years to grow the biotech industry to $100 bn by 2025’
Make bio-manufacturing the next big opportunity after generics for India. Invest $4-5 billion each year (Rs 24,000 to 30,000…
‘A new National Health Policy needs to be rolled out ’
A high level FICCI delegation led by Sidharth Birla, President, FICCI met the Union Health and Family Welfare Minister Dr Harsh…
Restructuring Infrastructure
A series of warning letters and import alerts seem to have convinced pharmaceutical companies to plug the loopholes in plant…
Clustering for comfort
The proposed Cluster Development Programme for the Pharma Sector (CDP-PS), a part of the 12th Five Year Plan, has received a…